🇺🇸 sodium fluorescein in United States
25 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 25
Most-reported reactions
- Loss Of Consciousness — 4 reports (16%)
- Nausea — 4 reports (16%)
- Vomiting — 3 reports (12%)
- Anaphylactic Shock — 2 reports (8%)
- Angioedema — 2 reports (8%)
- Asthenia — 2 reports (8%)
- Cold Sweat — 2 reports (8%)
- Dizziness — 2 reports (8%)
- Drug Hypersensitivity — 2 reports (8%)
- Hyperhidrosis — 2 reports (8%)
Other Ophthalmology approved in United States
Frequently asked questions
Is sodium fluorescein approved in United States?
sodium fluorescein does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for sodium fluorescein in United States?
University Hospitals Cleveland Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.